{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:52:09Z","timestamp":1781635929307,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dalio Center for Health Justice"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Injection-related severe bacterial infections (SBIs), including skin and soft tissue infections, endocarditis, and osteomyelitis, are rising in prevalence in the United States and disproportionately affect people who inject drugs (PWID). Hospitalization for SBI presents a critical opportunity to engage patients in addiction and infectious disease care, yet healthcare systems often fail to capitalize on this moment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This qualitative study explores the perspectives of 22 clinical stakeholders, including physicians, surgeons, nurses, and social workers, on barriers and strategies to improve care for hospitalized people who inject drugs (PWID) with substance use disorders (SUDs). Participants were recruited through purposive sampling from a large urban healthcare institution and selected external sites. Semi-structured interviews were conducted and analyzed using a thematic analysis approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three core themes emerged: empowering clinical teams, enhancing patient care, and improving interdisciplinary workflows. Participants called for stronger provider education on substance use disorders, stigma reduction, and communication; expanded access to addiction consults, harm reduction tools, peer navigators, and flexible discharge options such as OPAT with coordinated follow-up. Barriers included limited staffing, inconsistent access to addiction specialists and peers, and institutional inertia around discharge and reimbursement. Stakeholders highlighted telemedicine and structured interdisciplinary communication as means to prevent care fragmentation, noting that patient-directed discharges often stem from unmanaged withdrawal, stigma, and mistrust within existing hospital systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings align with prior research on addiction consult models and highlight emerging support for hybrid care delivery models that integrate harm reduction, peer support, and telehealth. However, practical and structural limitations, such as policy constraints, funding gaps, and misaligned institutional incentives, remain significant obstacles. This study contributes to a growing body of literature calling for targeted, feasible interventions that can transform hospital-based care for PWID with SBIs. Future work should address patient perspectives and evaluate outcomes of proposed strategies to guide institutional investment and policy reform.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13722-026-00651-9","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T11:04:21Z","timestamp":1770635061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving hospital-based care for patients with injection-drug related infections: provider perspectives"],"prefix":"10.1186","volume":"21","author":[{"given":"Giselle","family":"Appel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Vien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Avery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi N.","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"9","key":"651_CR1","doi-asserted-by":"publisher","first-page":"e0239700","DOI":"10.1371\/journal.pone.0242165","volume":"15","author":"J Capizzi","year":"2020","unstructured":"Capizzi J, Leahy J, Wheelock H, et al. Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018. PLoS ONE. 2020;15(9):e0239700. https:\/\/doi.org\/10.1371\/journal.pone.0242165.","journal-title":"PLoS ONE"},{"issue":"7","key":"651_CR2","doi-asserted-by":"publisher","first-page":"E37","DOI":"10.1093\/cid\/ciaa008","volume":"71","author":"NL McCarthy","year":"2020","unstructured":"McCarthy NL, Baggs J, See I, et al. Bacterial infections associated with substance use disorders, large cohort of united States hospitals, 2012\u20132017. Clin Infect Dis. 2020;71(7):E37\u201344.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"651_CR3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","volume":"35","author":"MV Ronan","year":"2016","unstructured":"Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312. Health Aff. 2016;35(5):832\u20137.","journal-title":"Health Aff"},{"issue":"1","key":"651_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.7326\/M18-2124","volume":"170","author":"AJ Schranz","year":"2019","unstructured":"Schranz AJ, Fleischauer A, Chu VH, et al. Trends in drug use\u2013associated infective endocarditis and heart valve surgery, 2007 to 2017: A study of statewide discharge data. Ann Intern Med. 2019;170(1):31\u201340.","journal-title":"Ann Intern Med"},{"key":"651_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciac543","volume":"76","author":"H Bradley","year":"2023","unstructured":"Bradley H, Hall E, Asher A, et al. Estimated number of people who inject drugs in the united States. Clin Infect Dis. 2023;76:96\u2013102. https:\/\/doi.org\/10.1093\/cid\/ciac543.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"651_CR6","doi-asserted-by":"publisher","first-page":"S429","DOI":"10.1093\/infdis\/jiaa149","volume":"222","author":"I See","year":"2020","unstructured":"See I, Gokhale RH, Geller A, et al. National public health burden estimates of endocarditis and skin and soft-tissue infections related to injection drug use: a review. J Infect Dis. 2020;222(Suppl 5):S429\u201336.","journal-title":"J Infect Dis"},{"issue":"Suppl 5","key":"651_CR7","doi-asserted-by":"publisher","first-page":"S494","DOI":"10.1093\/infdis\/jiaa025","volume":"222","author":"CN Price","year":"2020","unstructured":"Price CN, Solomon DA, Johnson JA, et al. Feasibility and safety of outpatient parenteral antimicrobial therapy in conjunction with addiction treatment for people who inject drugs. J Infect Dis. 2020;222(Suppl 5):S494\u20138. https:\/\/doi.org\/10.1093\/infdis\/jiaa025.","journal-title":"J Infect Dis"},{"issue":"1","key":"651_CR8","first-page":"1","volume":"5","author":"Philadelphia Department of Public H","year":"2020","unstructured":"Philadelphia Department of Public Health. Hospitalizations for infections related to injection drug Use, 2013\u2013 2018. CHART. 2020;5(1):1\u20136.","journal-title":"CHART"},{"issue":"11","key":"651_CR9","doi-asserted-by":"publisher","first-page":"e3661","DOI":"10.1093\/cid\/ciaa1346","volume":"73","author":"JA Barocas","year":"2021","unstructured":"Barocas JA, Eftekhari Yazdi G, Savinkina A, Nolen S, Savitzky C, Samet JH, Englander H, Linas BP. Long-term infective endocarditis mortality associated with injection opioid use in the united states: a modeling study. Clin Infect Dis. 2021;73(11):e3661\u20139. https:\/\/doi.org\/10.1093\/cid\/ciaa1346.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"651_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/cid\/ciaa062","volume":"72","author":"JA Barocas","year":"2021","unstructured":"Barocas JA, Morgan JR, Wang J, McLoone D, Wurcel A, Stein MD. Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis. Clin Infect Dis. 2021;72(3):472\u20138.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"651_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12954-022-00624-6","volume":"19","author":"A Hrycko","year":"2022","unstructured":"Hrycko A, Mateu-Gelabert P, Ciervo C, Linn-Walton R, Eckhardt B. Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage. Harm Reduct J. 2022;19(1):41. https:\/\/doi.org\/10.1186\/s12954-022-00624-6. PMID: 35501854; PMCID: PMC9063270.","journal-title":"Harm Reduct J"},{"key":"651_CR12","doi-asserted-by":"publisher","unstructured":"Avery JD, Taylor KE, Kast KA, Kattan J, Gordon-Elliot J, Mauer E, Avery JJ, Penzner JB. Attitudes toward individuals with mental illness and substance use disorders among resident physicians. Prim Care Companion CNS Disord. 2019;21(1):18m02382. https:\/\/doi.org\/10.4088\/PCC.18m02382. PMID: 30620451.","DOI":"10.4088\/PCC.18m02382"},{"key":"651_CR13","unstructured":"United States Department of Health & Human Services (HHS). National partnership for action to end health disparities: Offices of Minority Health. Washington, DC; 2011."},{"issue":"22","key":"651_CR14","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMp1609535","volume":"375","author":"RR Hardeman","year":"2016","unstructured":"Hardeman RR, Medina EM, Kozhimannil KB. Structural racism and supporting black lives \u2014 the role of health professionals. N Engl J Med. 2016;375(22):2113\u20135.","journal-title":"N Engl J Med"},{"issue":"5","key":"651_CR15","first-page":"295","volume":"108","author":"CJ King","year":"2016","unstructured":"King CJ, Redwood Y. The health care institution, population health, and black lives. J Natl Med Assoc. 2016;108(5):295\u20137.","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"651_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.amjmed.2021.08.007","volume":"135","author":"A Appa","year":"2022","unstructured":"Appa A, Adamo M, Le S, Davis J, Winston L, Doernberg SB, Chambers H, Martin M, Hills NK, Coffin P, Jain V. Patient-Directed discharges among persons who use drugs hospitalized with invasive Staphylococcus aureus infections: opportunities for improvement. Am J Med. 2022;135(1):91\u20136. Epub 2021 Sep 9. PMID: 34508704; PMCID: PMC11552656.","journal-title":"Am J Med"},{"issue":"3","key":"651_CR17","doi-asserted-by":"publisher","first-page":"ofab083","DOI":"10.1093\/ofid\/ofab083","volume":"8","author":"AG Ceniceros","year":"2021","unstructured":"Ceniceros AG, Shridhar N, Fazzari M, Felsen U, Fox AD. Low use of outpatient parenteral antimicrobial therapy for drug use-associated infective endocarditis in an urban hospital system. Open Forum Infect Dis. 2021;8(3):ofab083. https:\/\/doi.org\/10.1093\/ofid\/ofab083.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"651_CR18","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1017\/ash.2022.330","volume":"3","author":"G Agnihotri","year":"2023","unstructured":"Agnihotri G, Gross AE, Seok M, Yen CY, Khan F, Ebbitt LM, Gay C, Bleasdale SC, Sikka MK, Trotter AB. Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e33.","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"issue":"7","key":"651_CR19","doi-asserted-by":"publisher","first-page":"ofae364","DOI":"10.1093\/ofid\/ofae364","volume":"11","author":"SA Fabricant","year":"2024","unstructured":"Fabricant SA, Abramson EL, Hutchings K, Vien A, Scherer M, Kapadia SN. PICC your poison: resident beliefs and attitudes regarding discharge parenteral antibiotics for patients who inject drugs. Open Forum Infect Dis. 2024;11(7):ofae364. https:\/\/doi.org\/10.1093\/ofid\/ofae364. PMID: 38994443; PMCID: PMC11237634.","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"651_CR20","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","volume":"174","author":"JM Liebschutz","year":"2014","unstructured":"Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, Dossabhoy S, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369\u201376.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"651_CR21","doi-asserted-by":"publisher","first-page":"e2016228","DOI":"10.1001\/jamanetworkopen.2020.16228","volume":"3","author":"SD Kimmel","year":"2020","unstructured":"Kimmel SD, Walley AY, Li Y, Linas BP, Lodi S, Bernson D, Weiss RD, et al. Association of treatment with medications for opioid use disorder with mortality after hospitalization for injection drug use-associated infective endocarditis. JAMA Netw Open. 2020;3(10):e2016228.","journal-title":"JAMA Netw Open"},{"key":"651_CR22","doi-asserted-by":"publisher","unstructured":"Rogers ES, Swarbrick M. Peer-delivered services: current trends and innovations. Psychiatr Rehabil J. 2016;39(3):193-6. https:\/\/doi.org\/10.1037\/prj0000223. PMID: 27618456.","DOI":"10.1037\/prj0000223"},{"key":"651_CR23","doi-asserted-by":"publisher","unstructured":"Stack E, Hildebran C, Leichtling G, Waddell EN, Leahy JM, Martin E, Korthuis PT. Peer recovery support services across the continuum: in community, hospital, corrections, and treatment and recovery agency settings - a narrative review. J Addict Med. 2022;16(1):93\u2013100. https:\/\/doi.org\/10.1097\/ADM.0000000000000810. PMID: 33560695; PMCID: PMC8339174.","DOI":"10.1097\/ADM.0000000000000810"},{"issue":"13","key":"651_CR24","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1049732315617444","volume":"26","author":"K Malterud","year":"2016","unstructured":"Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016;26(13):1753\u201360. https:\/\/doi.org\/10.1177\/1049732315617444. Epub 2016 Jul 10. PMID: 26613970.","journal-title":"Qual Health Res"},{"issue":"3","key":"651_CR25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/nhs.12048","volume":"15","author":"M Vaismoradi","year":"2013","unstructured":"Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398\u2013405. PMID: 23480423.","journal-title":"Nurs Health Sci"},{"issue":"3","key":"651_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/ADM.0000000000000558","volume":"14","author":"M Hayden","year":"2020","unstructured":"Hayden M, Moore A. Attitudes and approaches towards repeat valve surgery in recurrent injection drug use-associated infective endocarditis: a qualitative study. J Addict Med. 2020;14(3):217\u201323. https:\/\/doi.org\/10.1097\/ADM.0000000000000558.","journal-title":"J Addict Med"},{"issue":"3","key":"651_CR27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.athoracsur.2021.12.068","volume":"116","author":"AG Wurcel","year":"2023","unstructured":"Wurcel AG, Zubiago J, Reyes J, Smyth E, Balsara KR, Avila D, Barocas JA, Beckwith CG, Bui J, Chastain CA, Eaton EF, Kimmel S, Paras ML, Schranz AJ, Vyas DA, Rapoport A. Surgeons\u2019 perspectives on valve surgery in people with drug use-associated infective endocarditis. Ann Thorac Surg. 2023;116(3):492\u20138. https:\/\/doi.org\/10.1016\/j.athoracsur.2021.12.068.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"651_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/ADM.0000000000001295","volume":"18","author":"S Fielman","year":"2024","unstructured":"Fielman S, McNeely J, Fitzpatrick A, Kerensky T, Tomanovich M, Walley AY, Kosakowski S, King C, Appleton N, Weinstein ZM. A clinical guide to support the implementation of addiction consult services and the value of teaching and technical assistance. J Addict Med. 2024;18(3):215\u20137. https:\/\/doi.org\/10.1097\/ADM.0000000000001295.","journal-title":"J Addict Med"},{"issue":"6","key":"651_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/jamainternmed.2023.7282","volume":"184","author":"H Englander","year":"2024","unstructured":"Englander H, Thakrar AP, Bagley SM, Rolley T, Dong K, Hyshka E. Caring for hospitalized adults with opioid use disorder in the era of fentanyl: a review. JAMA Intern Med. 2024;184(6):691\u2013701. https:\/\/doi.org\/10.1001\/jamainternmed.2023.7282.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"651_CR30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1001\/jamainternmed.2024.3422","volume":"184","author":"J McNeely","year":"2024","unstructured":"McNeely J, Wang SS, Rostam Abadi Y, et al. Addiction consultation services for opioid use disorder treatment initiation and engagement: a randomized clinical trial. JAMA Intern Med. 2024;184(9):1106\u201315. https:\/\/doi.org\/10.1001\/jamainternmed.2024.3422.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"651_CR31","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamainternmed.2024.3436","volume":"184","author":"H Englander","year":"2024","unstructured":"Englander H. Opioid use disorder medications after hospitalization\u2014rethinking engagement in care. JAMA Intern Med. 2024;184(9):1115\u20136. https:\/\/doi.org\/10.1001\/jamainternmed.2024.3436.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"651_CR32","doi-asserted-by":"publisher","first-page":"e2420737","DOI":"10.1001\/jamanetworkopen.2024.20737","volume":"7","author":"Y Bao","year":"2024","unstructured":"Bao Y, Zhang H, Hutchings K, Harris RA, Calderbank T, Schackman BR. Medicaid-covered peer support services used by enrollees with opioid use disorder. JAMA Netw Open. 2024;7(7):e2420737. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.20737.","journal-title":"JAMA Netw Open"},{"key":"651_CR33","doi-asserted-by":"publisher","first-page":"209560","DOI":"10.1016\/j.josat.2024.209560","volume":"168","author":"AM Bunting","year":"2025","unstructured":"Bunting AM, Fawole A, Fernando J, Appleton N, King C, Textor L, Schatz D, McNeely J. Staff perspectives of barriers and facilitators to implementation of the consult for addiction treatment and care in hospitals (CATCH) program in new York City safety net hospitals. J Subst Use Addict Treat. 2025;168:209560. https:\/\/doi.org\/10.1016\/j.josat.2024.209560.","journal-title":"J Subst Use Addict Treat"},{"key":"651_CR34","first-page":"3488","volume":"2020","author":"JT Lai","year":"2020","unstructured":"Lai JT, Chapman BP, Carreiro SP, Costigan AD, Rodriguez-Perez KM, Gonzalez G, Babu KM. A pilot study of a Telemedicine-based substance use disorder evaluation to enhance access to treatment following Near-Fatal opioid overdose. Proc Annu Hawaii Int Conf Syst Sci. 2020;2020:3488\u201396. Epub 2020 Jan 7. PMID: 32015694; PMCID: PMC6996105.","journal-title":"Proc Annu Hawaii Int Conf Syst Sci"},{"issue":"11","key":"651_CR35","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1177\/07067437241281068","volume":"69","author":"M Crocker","year":"2024","unstructured":"Crocker M, Huang A, Fung K, Stukel TA, Toulany A, Saunders N, Kurdyak P, Barker LC, Hauck TS, Rotenberg M, Hamovitch E, Vigod SN. Virtual versus In-Person Follow-up after a psychiatric emergency visit: A Population-Based cohort study. Can J Psychiatry. 2024;69(11):809\u201319. Epub 2024 Sep 23. PMID: 39308421; PMCID: PMC11562897.","journal-title":"Can J Psychiatry"},{"issue":"10","key":"651_CR36","doi-asserted-by":"publisher","first-page":"e2336914","DOI":"10.1001\/jamanetworkopen.2023.36914","volume":"6","author":"LR Hammerslag","year":"2023","unstructured":"Hammerslag LR, Mack A, Chandler RK, Fanucchi LC, Feaster DJ, LaRochelle MR, Lofwall MR, Nau M, Villani J, Walsh SL, Westgate PM, Slavova S, Talbert JC. Telemedicine buprenorphine initiation and retention in opioid use disorder treatment for medicaid enrollees. JAMA Netw Open. 2023;6(10):e2336914.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"651_CR37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10096-018-03461-3","volume":"38","author":"K O\u2019Callaghan","year":"2019","unstructured":"O\u2019Callaghan K, Tapp S, Hajkowicz K, Legg A, McCarthy KL. Outcomes of patients with a history of injecting drug use and receipt of outpatient antimicrobial therapy. Eur J Clin Microbiol Infect Dis. 2019;38(3):575\u201380. https:\/\/doi.org\/10.1007\/s10096-018-03461-3. Epub 2019 Jan 24. PMID: 30680563.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"651_CR38","doi-asserted-by":"publisher","first-page":"105760","DOI":"10.1016\/j.ypmed.2019.105760","volume":"128","author":"LC Fanucchi","year":"2019","unstructured":"Fanucchi LC, Walsh SL, Thornton AC, Lofwall MR. Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model. Prev Med. 2019;128:105760. https:\/\/doi.org\/10.1016\/j.ypmed.2019.105760. Epub 2019 Jun 26. PMID: 31251946.","journal-title":"Prev Med"},{"issue":"1","key":"651_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13722-024-00461-x","volume":"19","author":"SK Evans","year":"2024","unstructured":"Evans SK, Ober AJ, Korn AR, Peltz A, Friedmann PD, Page K, Murray-Krezan C, Huerta S, Ryzewicz SJ, Tarhuni L, Nuckols TK, Watkins KE, Danovitch I. Contextual barriers and enablers to Establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder. Addict Sci Clin Pract. 2024;19(1):31. https:\/\/doi.org\/10.1186\/s13722-024-00461-x.","journal-title":"Addict Sci Clin Pract"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-026-00651-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-026-00651-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-026-00651-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:56:32Z","timestamp":1781632592000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13722-026-00651-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["651"],"URL":"https:\/\/doi.org\/10.1186\/s13722-026-00651-9","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional research committee and with the Declaration of Helsinki and its later amendments. This study was approved by the Institutional Review Board at the Biomedical Research Association of New York (BRANY, #22-08-093-380).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}